Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VT021
- Development stage
- Unknown
- Lead developer
- VT Bio
- Administration
- Oral
01
Overview
VT021, also known as PM021, is a botanical functional material developed by VT Bio as a health functional food for the regulation of blood glucose levels in patients with diabetes. It was granted individual approval as a health functional food by the South Korean Ministry of Food and Drug Safety (MFDS) in 2010 (authorization number 2010-33). The product is derived from botanical sources and is designed to assist in blood sugar management as part of a dietary regimen. Unlike VT Bio's botanical medicines, VT021 is specifically categorized and marketed as a nutraceutical or health functional food rather than a pharmaceutical drug.
- Other names
- PM021PM-021PM 021
Beyond the preview
Go deeper on VT021.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VT021.